Rhinitis, Allergic: all 1,042 studies

Page 2 of 11. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of AllergiesCompletedNCT04162795Phase 4Results posted
• House Dust Mite Allergy Trial In ChildrenCompletedNCT04145219Phase 3Results posted
• Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)CompletedNCT03882047Phase 3Results posted
• Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)CompletedNCT03879772Phase 3Results posted
• Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)CompletedNCT03861559Phase 3Results posted
• Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)CompletedNCT03855228Phase 3Results posted
• Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)CompletedNCT03855189Phase 3Results posted
• Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy StudyCompletedNCT03682965Phase 2Results posted
• Mite Asthma Pediatric Immunotherapy TrialCompletedNCT03654976Phase 3Results posted
• Dupilumab As An Adjunct For Subcutaneous Grass ImmunotherapyCompletedNCT03558997Phase 2Results posted
• Randomized Evaluation of Ten Allergy Skin Prick Test DevicesCompletedNCT03509766Not applicableResults posted
• Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)CompletedNCT03463031Phase 3Results posted
• A Novel Biologic Therapy for Perennial Allergic RhinitisCompletedNCT03360071Phase 2Results posted
• Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic RhinitisCompletedNCT03290248Phase 1/2Results posted
• A Dose-finding Study of ASP4070CompletedNCT03101267Phase 2Results posted
• Clinical Response to Rhinovirus ChallengeCompletedNCT02910401Phase 2Results posted
• Effects of Broccoli Sprout Extract on Allergy RhinitisCompletedNCT02885025Phase 2Results posted
• Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)CompletedNCT02870205Phase 3Results posted
• Drug Utilization Study for Pirinase Hayfever ReliefCompletedNCT02856282Results posted
• Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)CompletedNCT02709538Phase 3Results posted
• The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic RhinosinusitisCompletedNCT02696850Phase 4Results posted
• Efficacy of 2LALERG (Homeopathic Drug) in Allergic Rhinitis Related to Grass PollenCompletedNCT02690935Phase 4Results posted
• Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)CompletedNCT02631551Phase 3Results posted
• A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic AsthmaCompletedNCT02596321Phase 3Results posted
• Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or UrticariaCompletedNCT02576041Phase 4Results posted
• Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-AllergyCompletedNCT02556801Phase 2Results posted
• Comparability and Standardization of Controlled Allergen Challenge FacilitiesCompletedNCT02543346Phase 4Results posted
• Subcutaneous Immunotherapy for Mouse in AdultsCompletedNCT02532179Phase 1/2Results posted
• Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)CompletedNCT02478398Phase 3Results posted
• Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated ARCompletedNCT02443805Phase 3Results posted
• A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)CompletedNCT02424539Phase 4Results posted
• Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic RhinitisCompletedNCT02402465Phase 4Results posted
• Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal SpraysCompletedNCT02397915Phase 4Results posted
• The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot EvaluationCompletedNCT02394600Phase 4Results posted
• Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)CompletedNCT02320396Phase 3Results posted
• To Study GSP 301 in Patients With Seasonal Allergic RhinitisCompletedNCT02318303Phase 2Results posted
• Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)CompletedNCT02256553Phase 4Results posted
• Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis PatientsTerminatedNCT02246920Phase 3Results posted
• Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic RhinoconjunctivitisCompletedNCT02245360Phase 3Results posted
• Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic RhinitisCompletedNCT02230696Phase 3Results posted
• Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in RussiaCompletedNCT02155881Phase 3Results posted
• Development of Human Nasal Challenge Models With Microbial Constituents and Grass PollenCompletedNCT02090374Not applicableResults posted
• Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course StudyCompletedNCT02005627Phase 2Results posted
• The Effects of Immunotherapy in the NoseCompletedNCT01985542Not applicableResults posted
• A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)CompletedNCT01957202Phase 2Results posted
• A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic RhinitisCompletedNCT01949051Phase 2Results posted
• Efficacy and Safety of SPARC1310 in Seasonal Allergic RhinitisCompletedNCT01940146Phase 2Results posted
• Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic RhinitisTerminatedNCT01921348Not applicableResults posted
• Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in AdolescentsCompletedNCT01919554Phase 1Results posted
• A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)CompletedNCT01918033Phase 3Results posted
• A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic RhinitisCompletedNCT01916226Phase 4Results posted
• Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)CompletedNCT01915823Phase 3Results posted
• Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With ARCompletedNCT01880840Phase 4Results posted
• Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)CompletedNCT01857063Phase 3Results posted
• MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009)CompletedNCT01852825Phase 1Results posted
• Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)CompletedNCT01852812Phase 3Results posted
• Allergic Rhinitis Changes the Sinus MicrobiomeCompletedNCT01852513Phase 4Results posted
• Clinical Equivalence Study of Mometasone Nasal SprayCompletedNCT01850823Phase 3Results posted
• Assessment of Fluticasone Propionate on Ocular Allergy SymptomsCompletedNCT01817790Phase 3Results posted
• 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic RhinitisCompletedNCT01794741Phase 3Results posted
• Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)CompletedNCT01783548Phase 3Results posted
• Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting ImmunotherapyCompletedNCT01777438Results posted
• Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)CompletedNCT01753739Phase 2Results posted
• Effect of Nasaleze on Nasal Challenge With AllergenTerminatedNCT01723397Not applicableResults posted
• A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic RhinitisCompletedNCT01723254Phase 1Results posted
• Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen AllergyCompletedNCT01720251Phase 2Results posted
• Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)CompletedNCT01700192Phase 3Results posted
• Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)CompletedNCT01697956Phase 3Results posted
• Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)CompletedNCT01678807Phase 1Results posted
• A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)CompletedNCT01673620Phase 3Results posted
• Immune-modulatory Effect of Probiotic Strain on Grass Pollen Allergic IndividualsCompletedNCT01660698Not applicableResults posted
• A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)CompletedNCT01654536Phase 4Results posted
• A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627)CompletedNCT01644617Phase 2Results posted
• Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic RhinitisCompletedNCT01630135Phase 3Results posted
• Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic RhinitisCompletedNCT01622231Phase 3Results posted
• Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced RhinitisCompletedNCT01603056Phase 3Results posted
• Safety Study of Levocetirizine and FexofenadineCompletedNCT01586091Phase 4Results posted
• Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic RhinitisCompletedNCT01578278Phase 2Results posted
• Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic DermatitisTerminatedNCT01577628Not applicableResults posted
• Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic RhinitisCompletedNCT01550471Phase 4Results posted
• Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)CompletedNCT01549340Results posted
• A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mLCompletedNCT01544348Phase 1Results posted
• Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber ModelCompletedNCT01527188Phase 2Results posted
• Effects of Whole Sprouts on Airway Allergic InflammationCompletedNCT01522703Not applicableResults posted
• Study of a Topical Nasal Spray to Ease the Symptoms of HayfeverCompletedNCT01500629Early Phase 1Results posted
• A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)CompletedNCT01469234Phase 4Results posted
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)CompletedNCT01458275Phase 3Results posted
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).CompletedNCT01451541Phase 3Results posted
• An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to PlaceboCompletedNCT01439815Phase 4Results posted
• Intranasal SB-705498 in Allergic Rhinitis (AR) PatientsCompletedNCT01424397Phase 2Results posted
• Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)CompletedNCT01413958Phase 3Results posted
• Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal SprayCompletedNCT01401465Phase 3Results posted
• A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)CompletedNCT01385371Phase 3Results posted
• Biomarkers of Cockroach Sublingual Immunotherapy 2CompletedNCT01380327Phase 1/2Results posted
• Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic RhinitisCompletedNCT01378429Phase 3Results posted
• A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose InhalerCompletedNCT01371786Phase 1Results posted
• Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic RhinitisCompletedNCT01365650Phase 1Results posted
• Effects of Phenylephrine on Nasal Congestion in Participants With Seasonal Allergic Rhinitis (P08156 AM2)(Completed)CompletedNCT01330017Phase 2Results posted
• Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal AllergiesCompletedNCT01307319Phase 3Results posted
• Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic RhinitisCompletedNCT01287364Phase 3Results posted

← Rhinitis, Allergic overview